IP3 receptor blockade fails to prevent intracellular Ca2+ release by ET-1 and alpha-thrombin
R S Mathias1, K Mikoshiba, T Michikawa
1Department of Pediatrics, University of California, San Francisco 94143, USA.
Abstract:
The effect of inositol 1,4,5-trisphosphate (IP3) receptor blockade on platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), endothelin-1 (ET-1), or alpha-thrombin receptor-mediated intracellular Ca2+ (Ca2+i) release was examined using fura 2 microspectrofluorometry in single Chinese hamster ovary cells and myoblasts. Blockade of the IP3 receptor was achieved by microinjection of heparin or monoclonal antibody (MAb) 18A10 into the IP3 type 1 receptor. Heparin completely inhibited Ca2+i release after flash photolysis with caged IP3 and after exposure to PDGF and FGF. In contrast, heparin failed to block Ca2+i release after alpha-thrombin and ET-1. After application of ligand, IP3 levels were five- to sevenfold higher for alpha-thrombin than for ET-1 or PDGF. IP3 levels after PDGF and ET-1 were comparable. Similar to heparin, MAb 18A10 blocked Ca2+i release after PDGF but failed to block Ca2+i release after ET-1 or alpha-thrombin. These data suggest that the mechanisms of Ca2+i release by tyrosine kinase and certain 7-transmembrane receptors may differ. Although both receptor types use the IP3-signaling system, the ET-1 and alpha-thrombin receptors may have a second, alternative mechanism for activating CA2+i release.
Insights
Inositol 1,4,5-trisphosphate (IP3) receptor blockade differentially affects calcium release. While heparin and MAb 18A10 block PDGF and FGF, they do not inhibit ET-1 or alpha-thrombin signaling.
Area of Science:
- Cellular signaling
- Molecular biology
- Calcium signaling pathways
Background:
- Platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), endothelin-1 (ET-1), and alpha-thrombin receptors mediate intracellular calcium (Ca2+i) release.
- Inositol 1,4,5-trisphosphate (IP3) receptors are key mediators in calcium release.
- Understanding differential signaling mechanisms is crucial for cell biology.
Purpose of the Study:
- To investigate the role of IP3 receptor blockade in mediating Ca2+i release induced by various growth factors and agonists.
- To elucidate potential differences in Ca2+i release mechanisms among different receptor types.
Main Methods:
- Fura 2 microspectrofluorometry was employed in single Chinese hamster ovary cells and myoblasts.
- IP3 receptor blockade was achieved via microinjection of heparin or monoclonal antibody (MAb) 18A10.
- Cells were stimulated with caged IP3, PDGF, FGF, ET-1, or alpha-thrombin to assess Ca2+i release.
Main Results:
- Heparin completely inhibited Ca2+i release induced by caged IP3, PDGF, and FGF, but not by alpha-thrombin or ET-1.
- MAb 18A10 blocked Ca2+i release stimulated by PDGF but not by ET-1 or alpha-thrombin.
- IP3 levels were significantly higher for alpha-thrombin stimulation compared to ET-1 or PDGF.
Conclusions:
- Tyrosine kinase receptors (PDGF, FGF) and certain 7-transmembrane receptors (ET-1, alpha-thrombin) utilize distinct Ca2+i release mechanisms.
- While both receptor types engage the IP3 signaling system, ET-1 and alpha-thrombin receptors may possess alternative pathways for Ca2+i release activation.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
IP3/DAG Signaling Pathway
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Intracellular Signaling Affects Focal Adhesions
Some...
Ligand-Gated Ion Channel Receptor: Gating Mechanism


